These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9620038)

  • 21. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895
    [No Abstract]   [Full Text] [Related]  

  • 23. ABO blood group discrepancies among blood donors in Regional Blood Transfusion Centre GTB Hospital, Delhi, India.
    Sharma T; Garg N; Singh B
    Transfus Apher Sci; 2014 Feb; 50(1):75-80. PubMed ID: 24314713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic and therapeutic problems in ABO hemolytic disease of the newborn].
    Sławek Z; Banaszkiewicz A; Pszeniczna E; Stolarz E; Walczak Z; Surowiec E
    Acta Haematol Pol; 1988; 19(1-2):104-10. PubMed ID: 3239364
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG).
    Coghill J; Comeau T; Shea T; Braddy L; Bandarenko N; Afenyi-Annan A; Harvey D
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):786-8. PubMed ID: 16785068
    [No Abstract]   [Full Text] [Related]  

  • 26. Protein-glycan interactions as targets of intravenous/subcutaneous immunoglobulin (IVIg/SCIg) preparations.
    von Gunten S
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):151-2. PubMed ID: 25546801
    [No Abstract]   [Full Text] [Related]  

  • 27. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy.
    Mohamed M; Bates G; Eastley B
    Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of IgG and IgM anti-A with synthetic oligosaccharides.
    Romano EL; Bhardwaj J; Kelly S; Olson M; Lamontagne LR; Leigh JB; Lauzon GJ
    Transplant Proc; 1987 Dec; 19(6):4479-83. PubMed ID: 3321604
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemolysis from platelet transfusion: call to action for an underreported reaction.
    Quillen K
    Transfusion; 2012 Oct; 52(10):2072-4. PubMed ID: 23110729
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcome of ABO-incompatible liver transplantation in children with no specific alloantibodies at the time of transplantation.
    Yandza T; Lambert T; Alvarez F; Gauthier F; Jacolot D; Huault G; Fabre M; Valayer J
    Transplantation; 1994 Jul; 58(1):46-50. PubMed ID: 8036707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and specificity of red cell antibodies in thalassemia patients in Albania.
    Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G
    Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic plasma exchange as a therapeutic modality for the treatment of IVIG complications.
    Welsh KJ; Bai Y
    J Clin Apher; 2015 Dec; 30(6):371-4. PubMed ID: 26123478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidences for the association of blood group determinants with the carcinoembryonic antigen molecule.
    Magous R; Lecou C; Bali JP
    Mol Immunol; 1980 Aug; 17(8):1039-43. PubMed ID: 6160390
    [No Abstract]   [Full Text] [Related]  

  • 34. Alloimmunization to platelet antigens.
    Nugent DJ
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):83-8. PubMed ID: 1509298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of alloantibodies and their associations: Balance sheet of 3 years at the Regional Center of Blood Transfusion in Rabat/Morocco and difficult in transfusion management].
    Achargui S; Zidouh A; Abirou S; Merhfour FZ; Monsif S; Amahrouch S; El Ghobre A; El Halhali M; Temmara H; El Hryfy A; Motqi M; Satty A; Kandili M; Aghri M; Hajjout K; Benajiba M
    Transfus Clin Biol; 2017 Nov; 24(4):422-430. PubMed ID: 28576386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural anti-A and anti-B of the ABO system: allo- and autoantibodies have different epitope specificity.
    Obukhova P; Korchagina E; Henry S; Bovin N
    Transfusion; 2012 Apr; 52(4):860-9. PubMed ID: 21981750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [K-Lymphocyte cytotoxicity: role of human blood group ABO, rhesus and P alloantibodies].
    Cartron J; Cartron JP; Lopez M; Mariotti M; Salmon C
    C R Seances Acad Sci D; 1979 May; 288(19):1501-4. PubMed ID: 113124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of the search for ABO system antibodies among the adolescent female population].
    Cwik J
    Ginekol Pol; 1987 Jun; 58(6):403-7. PubMed ID: 3666540
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fetomaternal transfusion, Rhesus immunization and prevention. II. Rhesus immunization and prevention].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1976; 38(3-4):79-134. PubMed ID: 826036
    [No Abstract]   [Full Text] [Related]  

  • 40. Predictors of Red Cell Alloimmunization in Kurdish Multi Transfused Patients with Hemoglobinopathies in Iraq.
    Al-Mousawi MM; Al-Allawi NA; Alnaqshabandi R
    Hemoglobin; 2015; 39(6):423-6. PubMed ID: 26327166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.